HR Execs on the Move

Ionetix

www.ionetix.com

 
Ionetix Corporation is a pioneering radiopharmaceutical end to end solutions provider for cardiac PET. Cardiac PET with Ammonia N-13.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ionetix.com
  • 1, Ferry Building
    San Francisco, CA USA 94111
  • Phone: 517.252.4069

Executives

Name Title Contact Details

Similar Companies

Sollis Therapeutics

Sollis Therapeutics is a privately held pharmaceutical company developing non-opioid analgesic products. Our first product is a long acting formulation of a compound with both analgesic and anti-inflammatory properties this combination is perfectly tailored to the treatment of severe neuropathic pain conditions such as sciatica.

Warner Health Care

Berkeley Premium Nutraceuticals currently offers six supplements to address issues including sexual health, fatigue, night vision, and cardiovascular health. The Company is also investigating new formulas to assist with other concerns, including prostate

Bellicum

Bellicum Pharmaceuticals, located near the Houston Medical Center, is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including both hematological and solid tumors, as well as orphan inherited blood disorders. We are developing next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (HSCT) and CAR T cell therapy. We are dedicated to creating an exceptional work environment and are passionate about working to provide innovative new treatment options that can improve health and save lives.

Genactis

Genactis is a Fort Washington, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Onyx Pharmaceuticals

At Onyx Pharmaceuticals, an Amgen subsidiary, our imperative is to build a leading cancer therapeutics company like no other, working toward a unified goal that drives us forward…to deliver breakthrough cancer treatments to patients with the urgency they deserve.   By working in collaboration with patient advocacy groups, healthcare providers and business partners, we push the boundaries of science and cancer therapeuticdevelopment.